Skip to main content
Log in

CHH 380

Chimeric Anti-CD7 Antibody, SDZ CHH 380

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kirkham BW, Thien F, Pelton BK, et al. Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis. J Rheumatol 1992 Sep; 19: 1348–52

    PubMed  CAS  Google Scholar 

  2. Lazarovits AI, Rochon J, Banks L, et al. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection. J Immunol 1993 Jun 1; 150: 5163–74

    PubMed  CAS  Google Scholar 

  3. Lazarovits AI, Rochon J, Banks L, et al. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection. Transplant Proc 1993 Feb; 25 (Pt 1): 820–2

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CHH 380. Drugs R&D 1, 73–74 (1999). https://doi.org/10.2165/00126839-199901010-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00024

Keywords

Navigation